Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-05

Clinical Trial Update: High Dose Oxytocin Nasal Spray for Treatment of Tinnitus [Phase 3]

View source ↗

Summary

Phase 3 trial of high-dose oxytocin nasal spray for tinnitus was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • high-dose oxytocin nasal spray (oxytocin)

Snippet

Sponsor: NYU Langone Health | Conditions: Tinnitus | Phase 3 | Status: TERMINATED | Results posted: 2022-10-05